Skip to content
Open access

MSMICA: computational metabolite identification in untargeted metabolomics by integrating MS, retention time, and biological evidence

Aug 2026 · bioRxiv · 0 citations
Biology

TL;DR

MSMICA applies multiple pieces of evidence to substantially improve metabolite identification coverage and accuracy for known metabolites and enables greater metabolite identifications, expanded metabolic pathway coverage, and data harmonization.

Abstract

Mass Spectrometry Metabolomics Identification Connection Algorithm (MSMICA) is an algorithm for automated metabolite identification in untargeted liquid chromatography-high-resolution mass spectrometry (LC-HRMS) analyses. Limitations in metabolite identification can occur due to the availability and cost of standards and prevent recognition of metabolic factors impacting human health and disease. MSMICA performs mass-to-charge-ratio matching with chemical structures and clusters of LC-HRMS features for adduct and isotope forms. A local optimization is then used to integrate retention time prediction, metabolite precursor-product and transporter correlations, and biospecimen-specific abundance information for metabolite identification. Applying MSMICA to various internal and external mammalian datasets, validation results showed a 96.2 ± 5.1% correct rate of metabolite identification. When multiple LC-HRMS datasets were used, MSMICA enabled greater metabolite identifications, expanded metabolic pathway coverage, and data harmonization. Thus, MSMICA applies multiple pieces of evidence to substantially improve metabolite identification coverage and accuracy for known metabolites.

Read PDF

Similar papers

Open access 2026

Comprehensive LC-MS Metabolomics Data Processing with notame R/Bioconductor Package.

Liquid chromatography-mass spectrometry (LC-MS) is widely used in metabolomics. Raw LC-MS data is relatively complex, consisting of molecular features originating not only from unique metabolites but also from redundant adducts, in-source fragments, artifacts, and impurities. It is also prone to signal intensity drift...

V. Koistinen, Retu Haikonen, Atte Lihtamo et al. · 1 citation
Sep 2026

Bridging Speed and Confidence in Metabolomics: A Retention Time and MS2-Guided HILIC-Orbitrap Workflow

Personalized treatment strategies are rising within modern medicine approaches to dynamic and heterogeneous diseases such as cancer. Human metabolism is important for the understanding of these diseases and their mechanisms, but metabolomics remains often unused in multiomics approaches due to practical challenges in...

Jonas Rösler, Constantin P. Krempe, Feyza Cansiz et al. · 0 citations
Open access Sep 2026

Improving lipid identification and quantification: chromatogram deconvolution for LC-MS/MS workflows

Abstract Motivation Lipidomics relies on mass spectrometry-based workflows to identify and quantify complex lipid species. Due to the modular architecture of lipids, including headgroups, backbones, and fatty acyl chains, distinct precursor ions often produce isobaric or identical fragment ions. This problem is amplifi...

Felix Niedermaier, Denise Wolrab-Frühauf, R. Ahrends et al. · 0 citations
Review Sep 2026

From Metabolomic Fingerprints to Therapeutic Leads: Integrating ‎LC-MS/GC-MS, Network Pharmacology, Molecular Dynamics, and ‎Artificial Intelligence in Natural-Product Drug Discovery

Natural products remain a major source of pharmacologically active scaffolds, but converting complex extracts into validated drug leads is still slow and uncertain. A major challenge is not metabolite detection itself, but establishing a reliable link between chemical identity, molecular target, mechanism of action, ex...

Rema A. Ballg, Salah Neghmouche Nacer · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.